Dean Anthony Fennell
University of Leicester · 255 works · 8,944 citations · h-index 47
Top works
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- Small-cell lung cancer
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Lung adenocarcinoma promotion by air pollutants
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
- Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
- Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
- Novel insights into mesothelioma biology and implications for therapy
- British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
- Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
- MicroRNA regulation of core apoptosis pathways in cancer
- Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
- The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
- Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.